Becton Dickinson & Co

BDXNYSE · USD
180.94USD0.00 (-0.25%)
889

Becton Dickinson & Co (BDX) Covered Calls

As of September 18, 2026, BDX has 64 covered call opportunities in the coming three months. Return ranges from 3.5 to 55.0% until expiration. Annualized return ranges from 10.5 to 101.7%. The nearest expiration is October 16, 2026. Maximum potential profit is $9,956.

Read more

Running BDX covered calls helps you generate consistent income from Becton Dickinson & Co's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Becton Dickinson & Co involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best BDX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if BDX stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling BDX covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Becton Dickinson & Co covered call is worth writing.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems.

Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Income-focused investors, long-term BDX holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling BDX covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Becton Dickinson & Co covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryMedical Instruments & Supplies
  • SectorHealthcare
  • IV percentile50.00% Neutral
  • Market cap (M$)49,286
  • 52 weeks high-6.28%
  • 52 weeks low41.78%
  • Analyst recommendationBuy
    2.24
  • Target price$193.00
    6.67% above the current stock price
  • Dividend
  • Payout ratio71.53%
  • Earnings date2026-11-05
  • P/E54.58
  • Future P/E13.61
  • EPS (ttm)3.32
  • EPS growth next 5 years7.80%

As of September 18, 2026

2026-10-1628195.007.770.051.001411.007.80101.65-0.03+0.11400.95
2026-11-2063210.0016.060.902.152996.0016.5695.93-0.50+0.1401.25
2026-12-1891220.0021.590.602.503966.0021.9287.92-0.33+0.121781.90
2027-03-19182260.0043.690.152.857921.0043.7887.79-0.08+0.0942.70
2027-01-15119230.0027.110.103.304916.0027.1783.33-0.06+0.1263.20
2027-03-19182250.0038.170.401.656946.0038.3976.99-0.22+0.0721.25
2026-10-1628190.005.010.601.95966.005.3469.59-0.33+0.22371.35
2026-12-1891210.0016.061.904.103096.0017.1168.63-1.05+0.211442.20
2027-01-15119220.0021.590.253.903931.0021.7366.64-0.14+0.15393.65
2026-11-2063200.0010.531.703.602076.0011.4766.47-0.94+0.2301.90

As of September 18, 2026

Sell covered calls with the data behind you

Find the best BDX covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial